These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 16649441)

  • 1. [Hemolytic-uremic syndrome, low C-3 and positive ANCA].
    Castellano I; Pereira LF; Gómez-Martino JR; Covarsí A
    Nefrologia; 2006; 26(1):146-7. PubMed ID: 16649441
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of antineutrophil cytoplasmic antibodies in the classic form of hemolytic uremic syndrome.
    Olavarria F; Mezzano S; Valderrama G
    Nephron; 1994; 66(2):235. PubMed ID: 8139748
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hemolytic uremic syndrome in childhood: study of several factors potentially related with its genesis].
    Olavarría F; Mezzano S; Reinoso S; Delucchi A; Prado V
    Rev Med Chil; 1994 Jan; 122(1):36-41. PubMed ID: 8066341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The complement system in hemolytic-uremic syndrome in childhood.
    Monnens L; Molenaar J; Lambert PH; Proesmans W; van Munster P
    Clin Nephrol; 1980 Apr; 13(4):168-71. PubMed ID: 7379368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antineutrophil cytoplasm and antielastase antibodies in hemolytic-uremic syndrome.
    Rollino C; Roccatello D; Menegatti E; Piccoli G
    Nephron; 1993; 65(2):320-1. PubMed ID: 8247202
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemolytic uremic syndrome with hypocomplementemia and deposits of IgM and C3 in the involved renal tissue.
    Gonzalo A; Mampaso F; Gallego N; Bellas C; Segui J; Ortuño J
    Clin Nephrol; 1981 Oct; 16(4):193-9. PubMed ID: 7028337
    [No Abstract]   [Full Text] [Related]  

  • 7. Complement dysfunction in hemolytic uremic syndrome.
    Zipfel PF; Skerka C
    Curr Opin Rheumatol; 2006 Sep; 18(5):548-55. PubMed ID: 16896298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Persistent activation of C3 in the hemolytic uremic syndrome].
    Gonzalo A; Sarrias J; Alsina J
    Rev Clin Esp; 1977 May; 145(4):281-3. PubMed ID: 866752
    [No Abstract]   [Full Text] [Related]  

  • 9. Complement evaluation in atypical hemolytic uremic syndrome: current concepts.
    Sethi SK; Jhaveri KD
    Saudi J Kidney Dis Transpl; 2012 Sep; 23(5):1074-6. PubMed ID: 22982929
    [No Abstract]   [Full Text] [Related]  

  • 10. Determination of anti-neutrophil cytoplasmic antibodies in small vessel vasculitis: Comparative analysis of different strategies.
    Vermeersch P; Vervaeke S; Blockmans D; van Hoovels L; Mariën G; Vanmaele H; Bossuyt X
    Clin Chim Acta; 2008 Nov; 397(1-2):77-81. PubMed ID: 18708041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antineutrophil cytoplasmic antibody (ANCA) testing of routine sera varies in different laboratories but concordance is greater for cytoplasmic fluorescence (C-ANCA) and myeloperoxidase specificity (MPO-ANCA).
    Pollock W; Jovanovich S; Savige J
    J Immunol Methods; 2009 Aug; 347(1-2):19-23. PubMed ID: 19490915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of hemolytic uremic syndrome with high concentration of circulating immune complex in the initial stage.
    Furuse A; Hattori S; Matsuda I
    Int J Pediatr Nephrol; 1983 Jun; 4(2):123-6. PubMed ID: 6618769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute renal failure in a 6-year-old girl who had anti-neutrophil cytoplasmic autoantibodies with myelo-peroxidase specificity as well as anti-glomerular basement membrane antibodies.
    Furuhashi K; Takahashi S; Inagaki T; Horinouchi K; Wada N; Hamazaki M; Ohzeki T
    Clin Nephrol; 2001 Oct; 56(4):336. PubMed ID: 11680665
    [No Abstract]   [Full Text] [Related]  

  • 14. Familial hypocomplementemic hemolytic uremic syndrome with HLA-A3,B7 haplotype.
    Carreras L; Romero R; Requesens C; Oliver AJ; Carrera M; Clavo M; Alsina J
    JAMA; 1981 Feb; 245(6):602-4. PubMed ID: 7452889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on evaluating complement in hemolytic uremic syndrome.
    Kavanagh D; Goodship TH
    Curr Opin Nephrol Hypertens; 2007 Nov; 16(6):565-71. PubMed ID: 18089972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-endothelial cell antibodies in antineutrophil cytoplasmic antibodies negative pauci-immune crescentic glomerulonephritis.
    Cong M; Chen M; Zhang JJ; Hu Z; Zhao MH
    Nephrology (Carlton); 2008 Jun; 13(3):228-34. PubMed ID: 18315705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of autoantibodies in clinical practice].
    Petitpierre S; Aubert V; Leimgruber A; Spertini F; Bart PA
    Rev Med Suisse; 2009 Apr; 5(199):823-31. PubMed ID: 19441748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis and thrombotic microangiopathy.
    Hirsch DJ; Jindal KK; Trillo AA
    Am J Kidney Dis; 1995 Aug; 26(2):385-6. PubMed ID: 7645547
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter: Haemolytic-uraemic syndrome: evidence for intravascular C3 activation.
    Stühlinger W; Kourilsky O; Kanfer A; Sraer JD
    Lancet; 1974 Sep; 2(7883):788-9. PubMed ID: 4143056
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful treatment of the postpartum atypical hemolytic uremic syndrome with eculizumab.
    Zschiedrich S; Prager EP; Kuehn EW
    Ann Intern Med; 2013 Jul; 159(1):76. PubMed ID: 23817717
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.